FA
EW icon

FDx Advisors’s Edwards Lifesciences EW Stock Holding History

FDx Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,632
Closed -$345K – 758
2022
Q2 		$345K Buy
+3,632
New +$376K 0.01% 580
2022
Q1 		– Sell
-2,093
Closed -$271K – 864
2021
Q4 		$271K Sell
2,093
-6,783
-76% -$791K 0.01% 737
2021
Q3 		$1M Sell
8,876
-2,162
-20% -$247K 0.03% 333
2021
Q2 		$1.14M Buy
11,038
+2,536
+30% +$239K 0.04% 307
2021
Q1 		$711K Buy
+8,502
New +$719K 0.03% 379
2020
Q1 		– Sell
-15,798
Closed -$1.23M – 553
2019
Q4 		$1.23M Sell
15,798
-1,020
-6% -$79.6K 0.07% 202
2019
Q3 		$1.23M Buy
16,818
+2,424
+17% +$170K 0.09% 191
2019
Q2 		$886K Sell
14,394
-432
-3% -$26.1K 0.03% 356
2019
Q1 		$946K Sell
14,826
-12,366
-45% -$706K 0.04% 307
2018
Q4 		$1.39M Buy
27,192
+309
+1% +$15.6K 0.11% 138
2018
Q3 		$1.56M Buy
26,883
+2,316
+9% +$113K 0.06% 254
2018
Q2 		$1.19M Sell
24,567
-19,203
-44% -$896K 0.04% 333
2018
Q1 		$2.04M Sell
43,770
-7,446
-15% -$323K 0.06% 283
2017
Q4 		$1.92M Sell
51,216
-2,277
-4% -$83.6K 0.05% 332
2017
Q3 		$1.95M Buy
53,493
+11,706
+28% +$446K 0.05% 320
2017
Q2 		$1.65M Sell
41,787
-1,470
-3% -$53.7K 0.05% 364
2017
Q1 		$1.36M Buy
43,257
+28,899
+201% +$905K 0.04% 419
2016
Q4 		$448K Buy
14,358
+3,150
+28% +$102K 0.01% 815
2016
Q3 		$450K Buy
11,208
+1,317
+13% +$49.6K 0.02% 664
2016
Q2 		$329K Sell
9,891
-4,044
-29% -$138K 0.01% 724
2016
Q1 		$410K Sell
13,935
-1,395
-9% -$38.5K 0.02% 639
2015
Q4 		$404K Buy
15,330
+4,746
+45% +$123K 0.02% 627
2015
Q3 		$251K Buy
10,584
+372
+4% +$8.98K 0.02% 672
2015
Q2 		$242K Buy
+10,212
New +$230K 0.01% 832
2015
Q1 		– Sell
-11,088
Closed -$235K – 1887
2014
Q4 		$235K Buy
+11,088
New +$223K 0.01% 806

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

FDx Advisors's EW Position: Q3 2022 in Review

FDx Advisors sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 3,632 shares — an estimated $345K sold.

FDx Advisors first reported a position in EW in Q4 2014 and held it in 25 quarters. The position peaked at $2.04M in Q1 2018. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • FDx Advisors reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • FDx Advisors sold 3,632 Edwards Lifesciences shares in Q3 2022, an estimated $345K.
  • FDx Advisors first reported a position in Edwards Lifesciences in Q4 2014 and held it in 25 quarters.
  • FDx Advisors's Edwards Lifesciences position peaked at $2.04M in Q1 2018.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on FDx Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.